Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential
International Journal of Molecular Sciences · 11.10.2025 · 26 (20) · 9907
DOI: 10.3390/ijms26209907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.10.2025. Verfasst von Stephanie Santos Suehiro Arcos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Toxinology (LETA) and Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo 05503-900, B…. Hauptthemen laut MEDLINE: Scorpion Venoms, Proteomics, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP, CNPq, CAPES.
Abstract (Originalsprache)
Scorpion venom is a rich source of bioactive compounds with significant potential for anticancer drug development. Its diverse molecular composition, including neurotoxins, antimicrobial peptides, and enzymes, provides a vast library for therapeutic innovation. Proteomic analyses have characterized venom composition in several species, while further functional assays have clarified their anticancer mechanisms. This review synthesizes current knowledge on scorpion venom-derived peptides with demonstrated anticancer activity, which selectively target ion channels, induce apoptosis, or disrupt tumor microenvironments. Where available, we highlight proteomic studies that have identified these components and discuss their structural features relevant to drug design. We also examine clinical applications and the challenges in translating venom peptides into therapies. The crucial and growing role of proteomics in this field, particularly for venom fractionation, component identification, and structural characterization, is critically evaluated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Applied Toxinology (LETA) and Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo 05503-900, Brazil.
- Laboratory of Structure and Functions of Biomolecules, Butantan Institute, São Paulo 05503-900, Brazil.
ORCID-Profile: Fernanda Calheta Vieira Portaro, Leo Kei Iwai
Förderung
- FAPESP
- CNPq
- CAPES
- São Paulo Research Foundation
- Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil) institutional fellowship
Zitieren
APA
Arcos, S. S. S., Aguiar, M. R. D. C., Oliveira, J., Silva, M. R. D., Pimentel, I. O. C., Dos Anjos, N. G., Machado, G. H. R. S., Evangelista, K. B., Portaro, F. C. V., & Iwai, L. K. (2025). Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential. International Journal of Molecular Sciences, 26(20), 9907. https://doi.org/10.3390/ijms26209907
Vancouver
Arcos SSS, Aguiar MRDC, Oliveira J, Silva MRD, Pimentel IOC, Dos Anjos NG, et al. Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(20):9907. doi:10.3390/ijms26209907
BibTeX
@article{Arcos2025,
author = {Arcos, Stephanie Santos Suehiro and Aguiar, Mariana Ramos da Cunha and Oliveira, Júlia de and Silva, Matheus Ramos da and Pimentel, Isabela de Oliveira Cavalcante and Dos Anjos, Nicolas Gamboa and Machado, Gustavo Henrique Rohr Souza and Evangelista, Kimberly Borges and Portaro, Fernanda Calheta Vieira and Iwai, Leo Kei},
title = {Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {9907},
doi = {10.3390/ijms26209907}
}
EUVIMED